Alkermes Plc Ownership

ALKS Stock  USD 29.32  0.07  0.24%   
The majority of Alkermes Plc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alkermes Plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alkermes Plc. Please pay attention to any change in the institutional holdings of Alkermes Plc as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Alkermes Plc in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Alkermes Plc, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkermes Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.

Alkermes Stock Ownership Analysis

About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Alkermes Plc was presently reported as 7.99. The company had not issued any dividends in recent years. Alkermes Plc had 2:1 split on the 15th of May 2000. Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Alkermes Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2211 people. For more info on Alkermes Plc please contact Richard Pops at 353 1 772 8000 or go to https://www.alkermes.com.

Alkermes Plc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alkermes Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alkermes Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alkermes Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Hopkinson Craig C. over two weeks ago
Disposition of 10471 shares by Hopkinson Craig C. of Alkermes Plc at 29.5262 subject to Rule 16b-3
 
Cooke Shane over two months ago
Acquisition by Cooke Shane of 6104 shares of Alkermes Plc subject to Rule 16b-3
 
Daglio David Angelo Jr. over two months ago
Acquisition by Daglio David Angelo Jr. of 17492 shares of Alkermes Plc at 23.4 subject to Rule 16b-3
 
David Gaffin over three months ago
Disposition of 2014 shares by David Gaffin of Alkermes Plc subject to Rule 16b-3
 
Alva Emily Peterson over three months ago
Disposition of 6104 shares by Alva Emily Peterson of Alkermes Plc subject to Rule 16b-3
 
Alva Emily Peterson over three months ago
Disposition of 3871 shares by Alva Emily Peterson of Alkermes Plc subject to Rule 16b-3
 
Wright Christopher I over three months ago
Disposition of 3301 shares by Wright Christopher I of Alkermes Plc subject to Rule 16b-3
 
Samuel Parisi over six months ago
Disposition of 2559 shares by Samuel Parisi of Alkermes Plc at 29.65 subject to Rule 16b-3
 
Richard Pops over six months ago
Acquisition by Richard Pops of 274328 shares of Alkermes Plc at 30.04 subject to Rule 16b-3
 
Michael Landine over six months ago
Disposition of 1308 shares by Michael Landine of Alkermes Plc at 32.18 subject to Rule 16b-3
 
Wilson Frank Anders over a year ago
Acquisition by Wilson Frank Anders of 5985 shares of Alkermes Plc subject to Rule 16b-3
 
Wright Christopher I over a year ago
Exercise or conversion by Wright Christopher I of 5957 shares of Alkermes Plc subject to Rule 16b-3

Alkermes Plc Outstanding Bonds

Alkermes Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alkermes Plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alkermes bonds can be classified according to their maturity, which is the date when Alkermes Plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Alkermes Stock Analysis

When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.